Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-15
2007-05-15
Marschel, Ardin H. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S399000, C548S338100, C544S331000
Reexamination Certificate
active
10719701
ABSTRACT:
Methods of inducing immune tolerance by administering an immunosuppressive agent and a compound represented by Formula (I) are disclosed:Additionally methods of suppressing an immune response by administering an immunosuppressive agent and a compound represented by Formula (I) are disclosed. Further disclosed are methods for treating autoimmune diseases by administering an immunosuppressive agent and a compound represented by Formula (I). The variables of Formula (I) are described herein.
REFERENCES:
patent: 5540931 (1996-07-01), Hewitt et al.
patent: 5654312 (1997-08-01), Andrulis, Jr. et al.
patent: 5795967 (1998-08-01), Aggarwal et al.
patent: 5801193 (1998-09-01), Ojo-Amaize et al.
patent: 5958413 (1999-09-01), Anagnostopulos et al.
patent: 5990103 (1999-11-01), Schonharting et al.
patent: 6020323 (2000-02-01), Cohen et al.
patent: 6030615 (2000-02-01), Bucala et al.
patent: 6204245 (2001-03-01), Siegel et al.
patent: 6211160 (2001-04-01), Wilson et al.
patent: 6235281 (2001-05-01), Stenzel et al.
patent: 6270766 (2001-08-01), Feldman et al.
patent: 6294170 (2001-09-01), Boone et al.
patent: 6299878 (2001-10-01), Pierpadi et al.
patent: 6306820 (2001-10-01), Bendele et al.
patent: 6331560 (2001-12-01), Shohami et al.
patent: 6337325 (2002-01-01), Schonharting et al.
patent: 6376665 (2002-04-01), Duan et al.
patent: 6420374 (2002-07-01), Bianco et al.
patent: 6432962 (2002-08-01), Horneman
patent: 6432968 (2002-08-01), Schonharting et al.
patent: 6503184 (2003-01-01), Ni et al.
patent: 6506569 (2003-01-01), Ni et al.
patent: 6509015 (2003-01-01), Salfeld et al.
patent: 2002/0119988 (2002-08-01), Sneddon et al.
patent: 0 401 747 (1990-12-01), None
patent: 0401747 (1990-06-01), None
patent: WO 94/08619 (1994-04-01), None
patent: WO 95/09652 (1995-04-01), None
patent: WO 98/39026 (1998-09-01), None
patent: WO-01/87849 (2001-05-01), None
patent: WO 01/87849 (2001-11-01), None
Hancock et al., Proc. Natl. Acad.Sci. vol. 93, pp. 13967-13972.
Yuan, X. et al., “A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection,”Transplantation 73(11):1736-1742 (2002).
Turner, D. M., et al., “A Genetic Marker of High TNF-α Production in Heart Transplant Recipients,”Transplantation, 60(10):1113-1117 (1995).
Couriel, D., et al., “THF-Alpha Inhibition for the Treatment of Chronic GVHD,”Blood, 10(11):847a (2002) Abstract.
Hancock, W. W., et al., “Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection,”Proc. Natl. Acad. Sci. USA93:13967-13972 (1996).
Gembeh Shirley V.
Genzyme Corporation
Hamilton Brook Smith & Reynolds PC
Marschel Ardin H.
LandOfFree
Induction of immune tolerance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Induction of immune tolerance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of immune tolerance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3815374